LEXX
Lexaria Bioscience Corp
NASDAQ: LEXX · HEALTHCARE · BIOTECHNOLOGY
$0.66
-4.34% today
Updated 2026-04-30
Market cap
$23.56M
P/E ratio
—
P/S ratio
64.01x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$0 – $2
Volume
0.2M
Lexaria Bioscience Corp (LEXX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-218562.00 | $29035.00 | $-36402.00 | $-330336.00 | $109837.00 | $135943.00 | $321000.00 | $321000.00 | $321000.00 | $-1.50M | $-660856.00 | $-1.55M | $-2.52M | $-3.01M | $-2.62M | $-3.99M | $-4.88M | $-5.88M | $-4.96M | $-10.45M |
| Capital expenditures | $2.09M | $582434.00 | $223826.00 | $285242.00 | $1.00M | $274132.00 | $91613.00 | $91613.00 | $91613.00 | $36989.00 | $20102.00 | $9699.00 | $85399.00 | $769165.00 | $33645.00 | $79493.00 | $49191.00 | $169610.00 | $43017.00 | $24643.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $75469.00 | $56912.00 | $161366.00 | $179789.00 | $11336.00 | $21279.00 | $820892.00 | $820892.00 | $256051.00 | $122015.00 | $113044.00 | $2.60M | $626692.00 | $1.14M | $410007.00 | $752591.00 | $170382.00 | $492236.00 | $859494.00 |
| Free cash flow | $-2.31M | $-553399.00 | $-260228.00 | $-615578.00 | $-892793.00 | $-138189.00 | $229387.00 | $229387.00 | $229387.00 | $-1.54M | $-680958.00 | $-1.56M | $-2.60M | $-3.77M | $-2.65M | $-4.07M | $-4.93M | $-6.05M | $-5.00M | $-10.48M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |